Our reporter Xu Jie trainee reporter Jin Weixing Zhang An
Recently, the Centralized Procurement Office of the Inter-Provincial Alliance of Oral Implant Systems officially released the "Announcement of Centralized Procurement of Oral Implant Systems (No. 1)", which clarified the procurement varieties, procurement rules, and follow-up work arrangements. content.
Previously, the National Medical Insurance Bureau has carried out special management of dental implant medical service charges and consumable prices, and the target of the whole-process regulation of dental implant medical service prices is 4,500 yuan per tooth.
"The advancement of centralized procurement will reduce the price of implants, which will generate a large number of demand for implants. For leading dental companies, under the background of centralized procurement, the advantages of cost control can be fully reflected." Senior Investment Consultant of Jufeng Investment Consultants Xie logistics said.
One of the highlights of this dental implant collection is that while all the participation requirements for public medical institutions are made, it is also clarified that private medical institutions designated by medical insurance need to participate in the collection of dental implants in accordance with the management requirements of the designated agreement, and encourage other medical institutions. Actively participate.
"Private medical institutions account for about 80% of the oral implant business market. Relevant private institutions can gradually improve service levels and increase income by reducing costs and increasing efficiency." said Qin Liang, a senior investment consultant at Dong Hi-Tech.
It is worth mentioning that many listed dental medical companies responded to this collection.
Lv Jianming, chairman of Tongce Medical, said at the 2022 semi-annual performance briefing that the company will actively respond to the centralized procurement policy and hope that the centralized procurement policy can be implemented.
The company has a large number of implant doctors to cover the growing demand for dental implants.
Meiya Optoelectronics’ board secretary previously stated in response to investors’ questions that the promotion of the centralized procurement policy will reduce the cost of high-end dental services to a certain extent.
Objectively speaking, the decline in the cost of high-end services will bring about a rapid increase in industry demand, which in turn will drive the increase in demand for key equipment.
Rongyu Group pointed out in an analyst meeting held in September that it will try its best to participate in centralized procurement without affecting the current external service prices.
Meng Shi, co-founder of Haobo Medical, believes that the implementation of the centralized procurement policy has helped the dental industry to establish a value anchor.
"This centralized procurement has re-enhanced the market and consumers' understanding of dental implants. From the underlying logic, anchoring the price of dental implants is equivalent to redefining the industry."
Xie Logistics said that this centralized procurement acted as an "anchor" for the price through the public hospital press conference, and gradually transferred the effectiveness of the regulatory target to non-public medical institutions, thereby guiding non-public medical institutions to reduce the high price level.
A number of securities companies have issued research reports pointing out that the implementation of centralized procurement will further promote the substitution of domestically produced implants for imported implants.
CITIC Securities said that the promotion of the centralized procurement policy will facilitate the rapid increase in the volume of domestic implant brands, and the process of import substitution is expected to continue to evolve.
Caitong Securities believes that domestic brands have cost-effective advantages, and the probability of winning bids in centralized procurement is high. It is optimistic that the market share of domestic products will increase after centralized procurement.
"The replacement of dental implants in China is a major trend." Deng Zhidong, general manager of Hainan Boao Medical Technology Co., Ltd., said that the mainstream dental implant brands in the domestic market are currently monopolized by foreign companies, and the prices are high.
Domestic brands have favorable prices, high cost performance, and have competitive advantages. After being included in centralized procurement, they will be more widely used, and gradually realize domestic substitution and become the mainstream of the market.
(Securities Daily)